Letter by González-Costello et al Regarding Article, "Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-mediated Amyloidosis: Analysis of the APOLLO Study"

José González-Costello^{1

2}, Carlos Casasnovas^{2

3}, Carles Díez-López¹

Affiliations

¹ Advanced Heart Failure and Heart Transplant Unit, Heart Disease Institute (J.G.-C., C.D.-L.), Bellvitge University Hospital, Bellvitge Biomedical Research Institute, Barcelona, Spain.
² Multidisciplinary Familiar Amyloidosis Unit (J.G.-C., C.C.), Bellvitge University Hospital, Bellvitge Biomedical Research Institute, Barcelona, Spain.
³ Neuromuscular Unit, Neurology Department (C.C.), Bellvitge University Hospital, Bellvitge Biomedical Research Institute, Barcelona, Spain.

PMID: 31283374
DOI: 10.1161/CIRCULATIONAHA.119.039645

Comment

Letter by González-Costello et al Regarding Article, "Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-mediated Amyloidosis: Analysis of the APOLLO Study"

José González-Costello et al. Circulation. 2019.

. 2019 Jul 9;140(2):e90-e91.

doi: 10.1161/CIRCULATIONAHA.119.039645. Epub 2019 Jul 8.

Authors

José González-Costello^{1

2}, Carlos Casasnovas^{2

3}, Carles Díez-López¹

Affiliations

¹ Advanced Heart Failure and Heart Transplant Unit, Heart Disease Institute (J.G.-C., C.D.-L.), Bellvitge University Hospital, Bellvitge Biomedical Research Institute, Barcelona, Spain.
² Multidisciplinary Familiar Amyloidosis Unit (J.G.-C., C.C.), Bellvitge University Hospital, Bellvitge Biomedical Research Institute, Barcelona, Spain.
³ Neuromuscular Unit, Neurology Department (C.C.), Bellvitge University Hospital, Bellvitge Biomedical Research Institute, Barcelona, Spain.

PMID: 31283374
DOI: 10.1161/CIRCULATIONAHA.119.039645

No abstract available

PubMed Disclaimer

Comment in

Response by Solomon to Letter Regarding Article, "Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study".
Solomon SD. Solomon SD. Circulation. 2019 Jul 9;140(2):e92-e93. doi: 10.1161/CIRCULATIONAHA.119.040941. Epub 2019 Jul 8. Circulation. 2019. PMID: 31283371 No abstract available.

Comment on

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.
Solomon SD, Adams D, Kristen A, Grogan M, González-Duarte A, Maurer MS, Merlini G, Damy T, Slama MS, Brannagan TH 3rd, Dispenzieri A, Berk JL, Shah AM, Garg P, Vaishnaw A, Karsten V, Chen J, Gollob J, Vest J, Suhr O. Solomon SD, et al. Circulation. 2019 Jan 22;139(4):431-443. doi: 10.1161/CIRCULATIONAHA.118.035831. Circulation. 2019. PMID: 30586695 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Letter by González-Costello et al Regarding Article, "Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-mediated Amyloidosis: Analysis of the APOLLO Study"

Affiliations

Letter by González-Costello et al Regarding Article, "Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-mediated Amyloidosis: Analysis of the APOLLO Study"

Authors

Affiliations

Comment in

Comment on

Similar articles

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Research Materials